---
figid: PMC9691330__OMCL2022-4661519.004
pmcid: PMC9691330
image_filename: OMCL2022-4661519.004.jpg
figure_link: /pmc/articles/PMC9691330/figure/fig4/
number: Figure 4
figure_title: ''
caption: 'BHF177 inactivates the NR2B-PKC-CaMKII-ERK-CREB pathway in vitro. The neurons
  were treated with BHF177, PMA, CaCl2, or EGF. (a) The mRNA expression of PKC and
  CaMKII in neurons determined using RT-qPCR. (b) The protein expression of PKC, CaMKII,
  p-ERK1/2, or p-CREB in neurons determined using immunoblotting. âˆ—p < 0.05 vs. normal
  neuronal cells, #p < 0.05 vs. neurons treated with BHF177.'
article_title: BHF177 Suppresses Diabetic Neuropathic Pain by Blocking PKC/CaMKII/ERK1/2/CREB
  Signaling Pathway through Activating GABAB Receptor.
citation: Boyu Liu, et al. Oxid Med Cell Longev. 2022;2022:4661519.
year: '2022'

doi: 10.1155/2022/4661519
journal_title: Oxidative Medicine and Cellular Longevity
journal_nlm_ta: Oxid Med Cell Longev
publisher_name: Hindawi

keywords:
---
